This page lists the SEC filings reported by CAPITAL VENTURES INTERNATIONAL.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | INOVIO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | Aeterna Zentaris Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | GENETIC TECHNOLOGIES LTD | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | Cyclacel Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | THRESHOLD PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | ImmunoCellular Therapeutics, Ltd. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | QUANTUM FUEL SYSTEMS TECHNOLOGIES WORLDWIDE, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | BIND Therapeutics, Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | Hongli Clean Energy Technologies Corp. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | OXIGENE INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | XOMA Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | TENGION INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | JA Solar Holdings Co., Ltd. | 0 | 0.0% | EDGAR |
| SC 13G | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | OLIN CORP | 8,460,035 | 5.1% | EDGAR |
| SC 13G | 2015-08-07 | CAPITAL VENTURES INTERNATIONAL | Perseon Corp | 850,000 | 8.7% | EDGAR |
| SC 13G | 2015-08-05 | CAPITAL VENTURES INTERNATIONAL | Ceres, Inc. | 400,000 | 5.5% | EDGAR |
| SC 13G | 2015-07-30 | CAPITAL VENTURES INTERNATIONAL | NETSCOUT SYSTEMS INC | 7,388,025 | 7.1% | EDGAR |
| SC 13G | 2015-07-24 | CAPITAL VENTURES INTERNATIONAL | DIGITAL ALLY INC | 439,883 | 8.7% | EDGAR |
| SC 13G | 2015-05-14 | CAPITAL VENTURES INTERNATIONAL | CYTORI THERAPEUTICS, INC. | 12,570,005 | 9.0% | EDGAR |
| SC 13G | 2015-05-08 | CAPITAL VENTURES INTERNATIONAL | INOVIO PHARMACEUTICALS, INC. | 4,250,000 | 6.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.